Clinical Trial Update: Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis [Phase 2]

View source ↗

Summary

A Phase 2 parallel-group trial evaluated the efficacy and safety of Loion® compared with 10% salicylic acid in patients with scalp psoriasis; the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Scalp Psoriasis

Drugs mentioned

• Loion®
• Salicylic acid (salicylic acid)

Snippet

Sponsor: G. Pohl-Boskamp GmbH & Co. KG | Conditions: Scalp Psoriasis | Phase 2 | Status: COMPLETED